NanoVita, a blockchain-powered health technology company, completed a strategic Series A investment from K24 Ventures and a Seed Round backed by UDS Space, CandaqCom, CGVFOF, and Susie Ventures. K24 Ventures announced the Series A on its platforms, while NanoVita disclosed the Seed Round completion separately. NanoVita develops blockchain infrastructure at the intersection of nanotechnology and AI bio-intelligence. The amounts raised in both rounds remain undisclosed.
Funding Overview
NanoVita announced two funding milestones recently. K24 Ventures completed its Series A investment in NanoVita. Separately, NanoVita closed its Seed Round with backing from four investors.
Key details include:
- Series A: K24 Ventures invested in NanoVita.
- Seed Round: UDS Space, CandaqCom, CGVFOF, and Susie Ventures participated as investors in NanoVita’s Seed Round.
- Funding amounts for both rounds are undisclosed.
These rounds support NanoVita’s work in technological innovation and ecosystem expansion.
About the Company
NanoVita operates in blockchain-powered health technology. The company focuses on the intersection of nanotechnology and AI bio-intelligence. NanoVita builds next-generation blockchain infrastructure for the Web3 space. The company positions these funding rounds as milestones for advancing its projects.
Investors
K24 Ventures led the Series A investment in NanoVita. This firm is a regulated digital hybrid crypto fund headquartered in Singapore and the UK. K24 Ventures specializes in digital asset investments.
The Seed Round investors in NanoVita are:
Market Context
NanoVita’s funding occurs amid growing interest in Web3 infrastructure and blockchain applications in health technology. K24 Ventures’ involvement highlights demand for digital asset-focused investments.
The Seed Round reflects early-stage confidence in nanotechnology and AI bio-intelligence combined with blockchain. Such rounds often fund prototype development and initial ecosystem building in competitive sectors like Web3 health tech. As part of broader web3 fundraising updates, NanoVita’s dual funding rounds highlight continued investor interest in emerging technologies that combine blockchain with advanced scientific innovation.
Regulated funds like K24 Ventures, based in Singapore and the UK, provide compliance advantages for crypto-related projects. NanoVita’s dual rounds signal structured growth from seed validation to Series A expansion.
